Amiodarone Hepatotoxicity

@article{Sung2012AmiodaroneH,
  title={Amiodarone Hepatotoxicity},
  author={P. Sung and S. Yoon},
  journal={Hepatology},
  year={2012},
  volume={55}
}
  • P. Sung, S. Yoon
  • Published 2012
  • Medicine
  • Hepatology
  • A 72-year-old Korean male was admitted because of sudden onset of abdominal distension. He had been treated with amiodarone 200 mg, felodipine 5 mg, hydrochlorothiazide 25 mg, and aspirin 100 mg per day for hypertension with atrial fibrillation for 5 years. Before starting medication, he had undergone ultrasonography of the liver and serum biochemical tests including liver chemistry and lipid profile, with all results being within the normal range. There was no evidence of hepatitis B and C… CONTINUE READING
    3 Citations

    References

    SHOWING 1-5 OF 5 REFERENCES
    Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
    • 211
    Histopathologic analysis of suspected amiodarone hepatotoxicity.
    • 129
    Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice.
    • 163
    Cationic Amphiphilic Drug-Induced Phospholipidosis
    • 281
    Amiodarone hepatotoxicity.
    • 27